Quantitative bone scanning.

R Perelli; G Ferlin

doi:10.1007/bf02908289

Home/Archive/PubMed

PubMed · 180585

Quantitative bone scanning.

R Perelli·G Ferlin

View original source ↗Export metadata ↓

Abstract

The use of a computer coupled on-line with the scintillation camera allows an improvement of the finding of skeletal scintigraphy realized with 99mTc-pyrophosphate, making possible the identification of the smallest bone lesions. It also makes possible the quantification of the uptake degree of the radioindicator demonstrating, in normal subjects, an uptake ratio between the various skeletal segments of 1.07 +/- 0.06. In 44 metastatic lesions the ratio was 1.80 +/- 0.32, whilst in 14 areas of slight hyperfixation of the tracer a value of 1.24 +/- 0.09 was found. Since we were dealing with patients suffering from metastatic bone neoplasms, the authors outline the possibility that the quantification of data will allow the demonstration of the bone metastases even more precociously than with traditional scintigraphix examination.

Explore related subjects

Bone Neoplasms Bone and Bones Diagnosis, Computer-Assisted Diphosphates Humans Neoplasm Metastasis Radionuclide Imaging Ribs Spinal Neoplasms Technetium Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

R Perelli, G Ferlin. Quantitative bone scanning.. https://doi.org/10.1007/bf02908289

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

[Half-body irradiation. An effective palliative treatment of widespread skeletal metastases].

In a large number of cancer patients, extensive skeletal metastases or myelomatosis induce vast suffering, such as intolerable pain and local complications of neoplastic bone destruction. Analgetic drugs frequently do not yield sufficient palliation. Irradiation of local fields often has to be repeated, because of tumour growth outside previously irradiated volumes. Wide field irradiation of the lower or upper half of the body causes significant relief of pain in most patients. Adequate pretreatment handling of patients, method of irradiation, and follow-up are of marked importance to reduce side effects, and are described as they are carried out at the Department of Oncology, Haukeland Hospital.

Bone Neoplasms↗

PubMed1992

Immunohistochemical study of bone GLA protein in primary bone tumors.

METHODS: The immunoreactivity of bone GLA protein (BGP) in primary bone tumors, including osteosarcoma, chondrosarcoma, malignant fibrous histiocytoma of bone (MFH), and giant cell tumor of bone (GCT), was investigated with anti-BGP rabbit serum and peroxidase-antiperoxidase complex. RESULTS: As to intracellular localization, BGP antigenicity was detected in 33 of 35 cases of osteosarcoma and 12 of 25 cases of chondrosarcoma. However, there were no positive findings in all 15 cases of MFH or 20 cases of GCT. In chondrosarcoma, the frequency of positively stained cases increased according to pathologic grading (i.e., 3 of 14 cases of Grade 1, 7 of 9 cases of Grade 2, and 2 of 2 cases of Grade 3). Although the multinucleated cells in MFH or GCT were not immunostained, BGP antigenicity was observed in the multinucleated cells of osteosarcoma (12 of 15 cases). In the matrix of osteosarcoma, BGP immunoreactivity of the tumorous osteoid was observed in 28 of 32 cases. However, in the matrices of chondrosarcoma, MFH, and GCT, BGP immunoreactivity was not observed. CONCLUSION: These results suggest that the immunohistochemical study of BGP is useful for the differential diagnosis of bone tumors.

Bone Neoplasms↗

PubMed1992

Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints.

Ewing's sarcoma (ES) and peripheral neuroepithelioma (PN) are related tumors, possibly of neural crest origin, which are cytogenetically characterized by the specific translocation t(11;22)(q24;q12). The cos5 locus, previously identified in the vicinity of the chromosome 22 breakpoint of this translocation, was shown by in situ hybridization on interphase nuclei to lie between VIIIF2 and LIF, two loci located on either side of the breakpoint and at a distance of less than 2,000 kb. The progressive expansion of this locus by chromosome walking led to the construction of a 300 kb contig, which finally crossed the breakpoint. The subsequent cloning of the two translocation junction fragments of a PN, followed by the molecular characterization of the translocation breakpoints of 20 ES and PN, showed that most chromosome 22 breakpoints are clustered within a small, 2 kb region. In contrast, the chromosome 11 breakpoints are scattered over a region of at least 40 kb. The translocation leads to the synthesis of chimeric transcript that links sequences from chromosomes 22 and 11. Finally, no evidence was found of any specific difference in the position of ES and PN translocation breakpoints.

Bone Neoplasms↗